Chimerix Inc: Diferență între versiuni
The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei Chimerix Inc listata cu simbolul US.CMRX ==Descriere companie== Chimerix, Inc. (www.chimerix.com) is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. The Company offers TEMBEXA (brincidofovir) is an antiviral for the treatment of smallpox in all age groups, including infants, and for patients who have difficulty swallowing. The Company's product Imipridones is...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
Chimerix, Inc. (www.chimerix.com) is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. The Company offers TEMBEXA (brincidofovir) is an antiviral for the treatment of smallpox in all age groups, including infants, and for patients who have difficulty swallowing. The Company's product Imipridones is a cancer therapies, which provides ONC201 for brain and other cancers, ONC206 for central nervous system cancer and ONC212 for pancreatic cancer and leukemia. The Company’s DSTAT is a glycosaminoglycan derivative of heparin, which is a treatment for hematologic malignancies, including newly diagnosed acute myeloid leukemia (AML) in combination with standard chemotherapy. | Chimerix, Inc. (www.chimerix.com) is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. The Company offers TEMBEXA (brincidofovir) is an antiviral for the treatment of smallpox in all age groups, including infants, and for patients who have difficulty swallowing. The Company's product Imipridones is a cancer therapies, which provides ONC201 for brain and other cancers, ONC206 for [[CENTRAL|central]] nervous system cancer and ONC212 for pancreatic cancer and leukemia. The Company’s DSTAT is a glycosaminoglycan derivative of heparin, which is a treatment for hematologic malignancies, including newly diagnosed acute myeloid leukemia (AML) in combination with standard chemotherapy. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||